These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32568111)

  • 21. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
    Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
    Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.
    van der Kolk NM; de Vries NM; Kessels RPC; Joosten H; Zwinderman AH; Post B; Bloem BR
    Lancet Neurol; 2019 Nov; 18(11):998-1008. PubMed ID: 31521532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in "de-novo" Parkinsonian subjects: a randomized controlled trial with 18-month follow-up.
    Ferrazzoli D; Ortelli P; Riboldazzi G; Maestri R; Frazzitta G
    J Neurol; 2018 Apr; 265(4):906-916. PubMed ID: 29442177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
    Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
    Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
    Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
    Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence therapy improves medication adherence and quality of life in people with Parkinson's disease: a randomised controlled trial.
    Daley DJ; Deane KH; Gray RJ; Clark AB; Pfeil M; Sabanathan K; Worth PF; Myint PK
    Int J Clin Pract; 2014 Aug; 68(8):963-71. PubMed ID: 24750544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.
    Artusi CA; Dwivedi AK; Romagnolo A; Pal G; Kauffman M; Mata I; Patel D; Vizcarra JA; Duker A; Marsili L; Cheeran B; Woo D; Contarino MF; Verhagen L; Lopiano L; Espay AJ; Fasano A; Merola A
    JAMA Netw Open; 2019 Feb; 2(2):e187800. PubMed ID: 30707228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson's disease: 5 years and beyond.
    Tsuboi T; Lemos Melo Lobo Jofili Lopes J; Moore K; Patel B; Legacy J; Ratajska AM; Bowers D; Eisinger RS; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    J Neurosurg; 2021 Aug; 135(2):601-610. PubMed ID: 33035998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
    Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
    J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
    Derost PP; Ouchchane L; Morand D; Ulla M; Llorca PM; Barget M; Debilly B; Lemaire JJ; Durif F
    Neurology; 2007 Apr; 68(17):1345-55. PubMed ID: 17452578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism.
    Chen YF; Tseng YL; Lan MY; Lai SL; Su CS; Liu JS; Chang YY
    J Neurol Sci; 2014 Nov; 346(1-2):255-9. PubMed ID: 25240444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A High-Intensity Multicomponent Agility Intervention Improves Parkinson Patients' Clinical and Motor Symptoms.
    Tollár J; Nagy F; Kovács N; Hortobágyi T
    Arch Phys Med Rehabil; 2018 Dec; 99(12):2478-2484.e1. PubMed ID: 29886075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patients.
    de Bie RM; Schuurman PR; Bosch DA; de Haan RJ; Schmand B; Speelman JD;
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):375-82. PubMed ID: 11511714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of physiotherapy on severity of motor symptoms and quality of life in patients with Parkinson disease.
    Cholewa J; Boczarska-Jedynak M; Opala G
    Neurol Neurochir Pol; 2013; 47(3):256-62. PubMed ID: 23821423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.
    Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Tison F; Rascol O;
    Eur J Neurol; 2017 Dec; 24(12):1532-1538. PubMed ID: 28940893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.